Gerd Auffarth

CIK 1649867 · last filed 2025-10-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.61M

Companies

3

Total Filings

19

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OTLK Director $1.22 $0 7 2025-10-03
Outlook Therapeutics, Inc. (OTLKW) Delisted Director $0.03 $0 6 2021-10-07
LENS Director 38,464 $41.84 $1.61M $0 6 2018-12-19

Recent Filings · Page 2 of 2

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-07-21 Outlook Therapeutics, Inc. (OTLKW) Delisted Grant (A) $0 EDGAR
2020-07-06 Outlook Therapeutics, Inc. (OTLKW) Delisted Grant (A) $0 EDGAR
2020-04-21 Outlook Therapeutics, Inc. (OTLKW) Delisted Grant (A) $0 EDGAR
2018-12-19 LENS Grant (A) $0 EDGAR
2018-07-20 LENS Grant (A) $0 EDGAR
2017-03-22 LENS Grant (A) +12,738 $0 EDGAR
2017-03-10 LENS Exer (X) +6,460 $19.4K EDGAR
2016-08-09 LENS Grant (A) +8,247 $0 EDGAR
2015-08-03 LENS Grant (A) +11,019 $0 EDGAR
Showing 1119 of 19
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.